Chiron deal cleared
This article was originally published in The Gray Sheet
Executive Summary
European Commission approves Novartis' $5.1 bil. acquisition of blood-test and vaccine producer Chiron, passing the deal into the hands of shareholders. In the U.S., FTC cleared the deal at the end of 2005. Chiron anticipates that the acquisition will be completed before the end of the second quarter. Chiron and Novartis began moving toward a merger in September 2005 (1"The Gray Sheet" Nov. 7, 2005, In Brief)...